Literature DB >> 8640694

United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.

W D Travis1, J Lubin, L Ries, S Devesa.   

Abstract

BACKGROUND: Lung carcinoma is now the most frequently diagnosed major cancer in the world and is also the most common cause of cancer deaths in males and females in the United States and worldwide. Based on trends in cigarette smoking and on analysis of lung cancer rates by birth cohort, it was predicted that a decline would occur in age-adjusted lung cancer rates, initially in males, and approximately 10 years later in females. We evaluated age-adjusted lung cancer incidence rates for changes in trends by race, sex and histologic type to determine if and when rates may have started declining.
METHODS: We analyzed population-based incidence data from the National Cancer Institute's Third National Cancer Survey conducted between 1969 and 1971 and from the Surveillance, Epidemiology and End-results (SEER) program conducted between 1974 and 1991. Age-adjusted rates were plotted by time period using a logarithmic scale for the ordinate. We used regression methods for grouped time-to-response data to fit a model to the disease rate for age, and calendar year to estimate the calendar year of maximum disease rate.
RESULTS: During this period, the overall age-adjusted lung cancer incidence rate rose from 37.8 to 68.2 per 100,000. Lung cancer rates in both white and black males climaxed around 1984 and declined subsequently. Furthermore, among white and black males, the rates of squamous cell carcinoma, small cell carcinoma, and large cell carcinoma declined after peaks in 1981 and 1982, 1986 and 1987, and 1986 and 1988, respectively. The rates for adenocarcinoma in black males peaked in 1987 whereas the rates in white males appeared to have plateaued between 1989 and 1991. Total lung cancer rates in males exceeded those in females, with rates in black males exceeding rates in white males. Age-adjusted lung carcinoma rates among white and black females continued to increase for all histologic types with the exception of large cell carcinoma among whites, bronchioloalveolar carcinoma among whites and blacks, and adenosquamous carcinoma among blacks.
CONCLUSIONS: The cumulative effect of these trends has resulted in a plateau of total lung carcinoma incidence in all persons combined, and a decline might be expected soon, as has already been observed among males. Most of these changes reflect past cigarette smoking patterns. Demonstration of declines and tapering increases among several population subgroups suggests impending reductions in the incidence and mortality rate for this highly fatal cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8640694     DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2464::AID-CNCR8>3.0.CO;2-M

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  40 in total

1.  Targeted therapies for locally advanced or metastatic squamous cell carcinoma of the lung.

Authors:  Thomas E Stinchcombe
Journal:  Curr Treat Options Oncol       Date:  2013-12

2.  Smoking reduces survival in young females with lung adenocarcinoma after curative resection.

Authors:  Ming Liu; Gening Jiang; Jiaan Ding; Jiang Fan; Wenxin He; Peng Zhang; Nan Song
Journal:  Med Oncol       Date:  2011-01-30       Impact factor: 3.064

3.  Comment: Gunsmoke--changing public attitudes toward smoking and firearms.

Authors:  A L Kellermann
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

4.  The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.

Authors:  Bing-Yen Wang; Jing-Yang Huang; Heng-Chung Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Wei-Heng Hung; Ya-Fu Cheng
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-08       Impact factor: 4.553

5.  Smoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study.

Authors:  Anna E Prizment; Hiroshi Yatsuya; Pamela L Lutsey; Jay H Lubin; Mark Woodward; Aaron R Folsom; Rachel R Huxley
Journal:  Am J Prev Med       Date:  2014-06       Impact factor: 5.043

6.  Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County.

Authors:  Keisha A Houston; Khadijah A Mitchell; Jessica King; Arica White; Bríd M Ryan
Journal:  J Thorac Oncol       Date:  2018-01-31       Impact factor: 15.609

Review 7.  Lung cancer health disparities.

Authors:  Bríd M Ryan
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

Review 8.  Ten years of disease-free survival between two diagnoses of small-cell lung cancer: a case report and a literature review.

Authors:  M Al-Ajam; A Seymour; M Mooty; A Leaf
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

9.  Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.

Authors:  Piyun Chao; Manjeet Deshmukh; Hilliard L Kutscher; Dayuan Gao; Sujata Sundara Rajan; Peidi Hu; Debra L Laskin; Stanley Stein; Patrick J Sinko
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

10.  Management and costs of treating lung cancer patients in a university hospital.

Authors:  Konstantin J Dedes; Thomas D Szucs; Stephan Bodis; Markus Joerger; Adam Lowy; Erich W Russi; Hans C Steinert; Walter Weder; Rolf A Stahel
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.